RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

J Natl Cancer Inst. 2015 Aug 6;107(9):djv204. doi: 10.1093/jnci/djv204. Print 2015 Sep.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / mortality*
  • Male
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / mortality*